Search

Your search keyword '"Heart Failure With Preserved Ejection Fraction"' showing total 10,183 results

Search Constraints

Start Over You searched for: Descriptor "Heart Failure With Preserved Ejection Fraction" Remove constraint Descriptor: "Heart Failure With Preserved Ejection Fraction"
10,183 results on '"Heart Failure With Preserved Ejection Fraction"'

Search Results

5. Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America

6. Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HF

7. Finerenone and Kidney Outcomes in Patients With Heart Failure: The FINEARTS-HF Trial

8. Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial

10. A Portuguese expert panel position paper on the management of heart failure with preserved ejection fraction – Part I: Pathophysiology, diagnosis and treatment

11. Left Ventricular Elastance With Resting Volumetric Transthoracic Echocardiography Identifies Different Phenotypes in Heart Failure With Preserved Ejection Fraction: A Retrospective Analysis of a Multicenter Prospective Observational Study

22. Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program

23. Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure

30. GLP-1 Receptor Agonist in Nonobese Patients with Type 2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction

32. Cardio-Oncology and Heart Failure: AL Amyloidosis for the Heart Failure Clinician: a Supplement to the Scientific Statement from the Heart Failure Society of America

34. The Multicenter STudy On a Precise algorithm for diagnosis of heart failure with preserved ejection fraction, STOP-HFPEF study: study protocol and design.

35. Characterization and Mortality Risk of Impaired Left Ventricular Filling in Chronic Obstructive Pulmonary Disease.

36. Liraglutide combined with HIIT preserves contractile apparatus and blunts the progression of heart failure in diabetic cardiomyopathy rats.

37. Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity.

38. The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF).

39. Challenges in Prognostication of an Older Adult with Severe Obesity and End-Stage Heart Failure: A Case Study.

40. 卡格列净联合沙库巴曲缬沙坦口服对非糖尿病射血分数保留心力衰竭的治疗效果观察.

41. 射血分数保留心力衰竭患者超声左心房容积指数与心脏周围脂肪厚度的关系.

43. Association between insulin resistance indices and outcomes in patients with heart failure with preserved ejection fraction.

44. Propensity score matched cohort study on magnesium supplementation and mortality in critically ill patients with HFpEF.

45. Cardiorenal Disease and Heart Failure with Preserved Ejection Fraction: Two Sides of the Same Coin.

46. Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension.

47. Effect of neutrophil elastase inhibitor sivelestat on cardiac fibrosis in HFpEF mice.

48. NLRP3 Expression and Its Predictive Role in Heart Failure with Preserved Ejection Fraction among Non-Valvular Atrial Fibrillation Patients.

49. Cardiorenal Syndrome in Heart Failure with Preserved Ejection Fraction: Insights into Pathophysiology and Recent Advances.

50. Association between hypoxemia and quality of life in patients with heart failure with preserved ejection fraction and sleep-disordered breathing.

Catalog

Books, media, physical & digital resources